Market Cap: $3.21B
GRAIL Inc. ( GRAL ) is grappling with severe challenges stemming from unexpected results in its NHS-Galleri trial, instigating legal battles and shaking investor confidence. The implications of this s…
GRAIL Inc. ( GRAL ) has recently found itself at the center of significant turmoil following the failure of its leading NHS-Galleri trial, raising alarms among its investors and stakeholders. The afte…
